Ashrafun Nessa

Ashrafun Nessa

Auto-generated profile, based on publicly available information

Ashrafun Nessa

Affiliation Department of Gynaecological Oncology, Bangladesh Medical University (BMU), Dhaka, Bangladesh

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2021 in IJID Regions
Verified
Journal Article
Open access
SSShahana Sharmin
Shahana Sharmin
BSBristy Sabikunnahar
Bristy Sabikunnahar
AAArpita Aditya
Arpita Aditya
MKMd Abdullah Al Kamran Khan
Md Abdullah Al Kamran Khan
ANAshrafun Nessa
Ashrafun Nessa
MYMahmuda Yasmin
Mahmuda Yasmin
Objective: Human Papillomavirus (HPV) is comprised of about 120 genotypic related viruses, classified into low- and high-risk HPVs, are capable of replicating inside the keratinocytes of skin or mucous membranes. Studies suggest that infections with HPV-16, HPV-18 have a higher rate of developing cancer. The aim of this study was to detect HPV early and estimate the genotype-specific prevalence of HPV in apparently healthy and asymptomatic females of Bangladesh. Method: After the cervical swab specimen collection, VIA test was performed to identify any type of abnormality in the cervix. A multiplex PCR amplification of HPV DNA using L1 consensus primer systems was done with type-specific primers followed by sequencing to detect HPV genotypes. Result: Amongst the 417 females, 121 were found to be HPV positive. The most prevalent high risk HPV genotypes were found to be HPV-16 and HPV-18. Different patient demographical parameters such as age, socioeconomic status, education, and history of first intercourse were also studied to find out the correlation with the HPV infection. Conclusion: Our results might provide some insights that influence on the development of cervical cancer. It also can help in better patient management, creating public health awareness, further testing, and implementation of existing vaccines.

23 January 2024 in BMC Public Health
Verified
Journal Article
Open access
PDF file
ANAshrafun Nessa
Ashrafun Nessa
SHShahadat Hossain
Shahadat Hossain
SUSheikh Md Nazim Uddin
Sheikh Md Nazim Uddin
RIRafiqul Islam
Rafiqul Islam
MKMuhammad Abdul Hannan Khan
Muhammad Abdul Hannan Khan
AAAbul Kalam Azad
Abul Kalam Azad
Introduction: To reduce the high prevalence of cervical cancers among the Bangladeshi women, the Government of Bangladesh established a national cervical cancer screening programme in 2005 for women aged 30 to 60 years. The District Health Information System Version 2 (DHIS2) based electronic aggregated data collection system is used since the year 2013. This study summarises data from the year 2014 to 2022 to assess the effectiveness of the electronic data collection system in understanding the outcome of the screening programme. Methods: This is a descriptive study based on secondary data extracted in MS Excel from the DHIS2-based electronic repository of the national cervical cancer screening programme of Bangladesh. The respondents were women aged 30–60 years, screened for cervical cancer using VIA (Visual Inspection of cervix with Acetic acid) method in 465 government health facilities. The data were collected on the participants’ residential location, month and year of screening, name and type of health facilities performing VIA, and VIA screening results. Results: The national screening programme reported a total 3.36 million VIA tests from 465 government hospitals in 8 years (2014 to 2022). The national average VIA-positivity rate was 3.6%, which varied from 1.4 to 9.5% among the districts. This national screening programme witnessed an exponential growth, year after year, with 83.3% increase in VIA test from 2014 to 2022. The primary and the secondary care hospitals were the highest collective contributors of VIA tests (86.2%) and positive cases (77.8%). The VIA-positivity rates in different hospital types varied widely, 7.0% in the medical university hospital, 5.7% in the medical college hospitals, 3.9% in the district/general hospitals, and 3.0% in the upazila health complexes. Conclusions: A national cervical cancer screening programme using VIA method and a DHIS2-based electronic data collection backbone, is effective, sustainable, and useful to understand the screening coverage, VIA positivity rate and geographic distribution of the participants and case load to initiate policy recommendations and actions. Decentralization of the screening programme and more efforts at the primary and secondary care level is required to increase screening performances.

9 April 2025 in BMC Global and Public Health
Verified
Journal Article
Open access
PDF file
ANAshrafun Nessa
Ashrafun Nessa
AAAbul Kalam Azad
Abul Kalam Azad
SUShekh Md. Nizam Uddin
Shekh Md. Nizam Uddin
MKMuhammad Abdul Hannan Khan
Muhammad Abdul Hannan Khan
SZShreshtha Zaman
Shreshtha Zaman
MKMohammad Abdus Salam Khan
Mohammad Abdus Salam Khan
The Government of Bangladesh established a visual inspection with acetic acid (VIA)-based cervical cancer screening programme at 600 primary, secondary and tertiary health facilities following a pilot programme in 2005. An aggregated data collection system was initiated using District Health Information System 2 (DHIS2) software in 2013 and a case-based electronic data registry system was developed utilising its “tracker” component since January 2018. The purpose of this study is to review the cervical cancer surveillance situation based on the data of the national cervical cancer screening, treatment and follow-up through the DHIS2-based electronic registry. Women aged 30 to 60 were enrolled in the DHIS2 electronic registry in health facilities of all tiers including the community clinics and screened for cervical cancer using the VIA method at Upazila Health Complexes and upper tiers. The VIA-positive women were referred for colposcopy in the nearest colposcopy centres. The screen-positive women were offered treatment and followed up at certain intervals following the national standard protocol. During each encounter, required data were captured in DHIS2. Anonymised data from the DHIS2 covering January 2018 to May 2023 were extracted and analysed for this study. A total of 1,562,963 women were enrolled in 497 screening facilities and 6398 community clinics. Among them, 1,557,002 (99.6%) availed VIA tests, and primary health facilities performed 74.4% enrolments and 72% VIA tests. Among screened women, 51,913 (3.3%) were VIA positive, of which only 20,954 (40.4%) attended for colposcopy. Among colposcopy-positive women, 6.3% (1,327) and 6.2% (1,302) women had cervical intraepithelial neoplasia (CIN) II/III and cervical carcinoma, respectively. Among women who received treatment for cervical precancer, 81.6% (5062) had thermal ablation, and 17.6% (1089) had loop electrosurgical excision procedure. Histopathology reports (n = 3079) revealed 16.1% (n = 495) of women had squamous cell carcinoma, 4.0% (n = 123) had micro-invasive squamous cell carcinoma, 11.7% (n = 36) had CIN II, and 8.1% (n = 250) had CIN III. The National Cervical Cancer Screening and Treatment Programme for women in Bangladesh using a DHIS2-based electronic case-based tracking system is effective in understanding the screening situation and can be a valuable lesson for other countries.

5 September 2023 in International Journal Of Community Medicine And Public Health
Verified
Journal Article
Open access
PDF file
ASAnjuman Sultana
Anjuman Sultana
SSShakila Jahan Shimu
Shakila Jahan Shimu
MFM. Jakanta Faika
M. Jakanta Faika
TIThrina Islam
Thrina Islam
NFNoor-E- Ferdous
Noor-E- Ferdous
ANAshrafun Nessa
Ashrafun Nessa
Background: Cervical cancer (CC) is an important cause of cancer death among Bangladeshi women and human papillomavirus (HPV) is the causative factor for developing CC. HPV vaccination is yet to be implemented as part of national immunization programme in Bangladesh. Method: The objective of this cross-sectional research was to evaluate the understanding of CC, HPV, and the willingness to accept HPV vaccination among parents of school-aged children (between 5-16 years) from grades 1-10 in the capital city of Bangladesh, Dhaka. The study was conducted from February 2020 to January 2021 by paper-based survey. Results: This study showed 86.6% of participants knew that CC is preventable and 98.6% knew that vaccine can prevent CC. Only 1.3% of the participants heard about HPV. Majority (97.1%) were interested in HPV vaccination to female family members. Knowledge about visual inspection with acetic acid (VIA) test, CC prevention and HPV vaccine were significantly associated with willingness to give vaccine. Gender, age, educational level and socioeconomic condition of respondents have no relation with vaccine acceptance (p>0.05). This study showed that total 1319 (45%) respondents sought the vaccine free of cost and personal relation as friends and family were major source of information (64.8%). Conclusions: The study's results revealed that a significant number of Bangladeshi parents were aware of CC, CC prevention, and HPV vaccination. Nonetheless, most participants expressed a willingness to vaccinate their female family members against HPV.

25 March 2024 in Cancer Screening and Prevention
Verified
Journal Article
Open access
ANAshrafun Nessa
Ashrafun Nessa
SBShirin Akter Begum
Shirin Akter Begum
SMSaif Ullah Munshi
Saif Ullah Munshi
FBFerdousy Begum
Ferdousy Begum
ACAfroza Chowdhury
Afroza Chowdhury
NFNoor- E- Ferdous
Noor- E- Ferdous
The government of Bangladesh adopted visual inspection of the cervix with acetic acid method for cervical cancer screening in the majority of the district and sub-district hospitals. Before alternative screening methods are adopted, the prevalence of high-risk human papillomavirus (HPV) genotypes among various geographical regions must be determined. Therefore, we aimed to determine the prevalence of high-risk HPV genotypes in urban and rural areas of Bangladesh.

9 May 2025 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
FIFoyjul Islam
Foyjul Islam
ANAshrafun Nessa
Ashrafun Nessa
QZQuazi Ahmed Zaki
Quazi Ahmed Zaki
SAShah Ali Akbar Ashrafi
Shah Ali Akbar Ashrafi
OQOmar Qayum
Omar Qayum
TSTahmina Shirin
Tahmina Shirin
Cervical cancer (CC) is the second most prevalent cancer among women in Bangladesh, with 9,640 new cases and 5,826 deaths annually. Since 2018, the Electronic Data Tracking with Population-Based Cervical and Breast Cancer Screening Program (EPCBCSP) has been implemented nationwide across 601 health centers, utilizing Visual Inspection with Acetic Acid (VIA) for CC screening. However, the system had not been evaluated until now. This study aims to assess the performance of EPCBCSP and identify its strengths and challenges. We evaluated EPCBCSP using the updated guidelines from the Centers for Disease Control and Prevention(CDC) in 2023. Data were collected from central level stakeholders and from stakeholders at one colposcopy and one VIA center in each of four selected divisions of Bangladesh. Interviews with 42 stakeholders assessed simplicity, flexibility, acceptability, stability and usefulness attributes. Data quality was assessed by surveillance data review. Percentage scores were calculated and ranked as follows: excellent (≥ 90%), Very good (≥ 80%- < 90%.), good (≥60%- < 80%), average (≥50%- < 60%) and poor (≤50%).The overall system performance was rated as good (score:77.20%). The system’s simplicity (score: 91.61%) and usefulness (score:91.61%) were ranked as “excellent”. The acceptability (score: 85.29%) was ranked as “very good and flexibility (score:71.90%) was rated as “good”. Stability (percentage score: 53.25%) was considered average. Furthermore, data quality was assessed as average based on missing values (13.11%.) Electronic data tracking system, instant test report availability and “see and treat” policies were identified as strengths by stakeholders, while dedicated staff shortages and motivating participants were main challenges. The evaluation EPCBCSP in Bangladesh indicates overall good performance, excelling in simplicity and usefulness. However, improvements are needed in stability and data quality. Strengthening surveillance efforts addressing shortages of dedicated staff and participant motivation will further enhance the effectiveness of the program, crucial for reducing CC burden.